Sfoglia per Autore
Mostrati risultati da 1 a 4 di 4
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology.
2016-01-01 Faustini, G; Longhena, F; Zaltieri, M; Pizzi, M; Benfenati, F; Bjorklund, A; Missale, C; Spano, Pf; Bellucci, A
Synapsin III knock-out reduces AAV-alpha-synuclein overexpression-related neuropathology in the nigrostriatal system
2017-01-01 Faustini, G; Longhena, F; Pizzi, M; Benfenati, F; Björklund, Anders Olov Hjalmar; Missale, C; Spano, Pf; Bellucci, A
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and synaptic protein’s redistribution
2017-01-01 Faustini, G; Longhena, F; Pizzi, M; Benfenati, F; Björklund, A; Spano, Pf; Bellucci, A
Validation of synapsin III as a therapeutic target for Parkinson’s disease in the AAV-mediated alpha-synuclein mouse model
2018-01-01 Faustini, G; Longhena, F; Pizzi, M; Benfenati, F; Björklund, A; Spano, Pf; Bellucci, A.
Mostrati risultati da 1 a 4 di 4
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile